{
    "URL": "https://doi.org/10.1371/journal.pntd.0006695",
    "Published": "August 9, 2018",
    "Subject_Areas": [
        "Drug research and development",
        "Tropical diseases",
        "Infectious diseases",
        "Drug therapy",
        "Tuberculosis",
        "Malaria",
        "Epidemiology",
        "Pediatrics"
    ],
    "Authors": {
        "Kirk W. Kerr": [
            "Office of Program and Strategic Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD United States of America"
        ],
        "Thomas C. Henry": [
            "Office of Planning, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD United States of America"
        ],
        "Kathleen L. Miller": [
            "Office of Orphan Products Development, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD United States of America",
            "Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC United States of America"
        ]
    }
}